肿瘤与癌旁非肿瘤区域的免疫浸润共同决定早期肺癌患者的临床结局
本研究对67例早期非小细胞肺癌(NSCLC)患者的119份样本(含52对肿瘤与癌旁非肿瘤样本)进行高深度RNA测序分析,发现癌旁非肿瘤样本的推断免疫浸润水平显著高于肿瘤样本,且配对样本间免疫浸润差异比单一区域表达更具预后价值,提示两区域提供互补的预后信息。
要点
- 癌旁非肿瘤样本的推断免疫浸润水平显著高于肿瘤样本。
- 肿瘤样本中特定免疫细胞类型浸润与总生存相关,癌旁样本中则不然。
- 配对样本间免疫浸润差异(肿瘤减非肿瘤)比任一区域表达更具预后价值。
核心结论
- 肿瘤与癌旁非肿瘤样本间存在显著免疫特征差异,两区域为早期NSCLC提供互补的预后价值。
研究设计与样本
- 研究分析了67例早期NSCLC患者的119份样本,包括52对肿瘤与癌旁非肿瘤样本,并进行高测序深度RNA测序分析。
主要发现
- 免疫相关基因在差异表达基因中高度富集,癌旁非肿瘤样本的推断免疫浸润水平显著高于肿瘤样本。
- 肿瘤样本中特定免疫细胞类型浸润与患者总生存相关,而癌旁非肿瘤样本中则未显示此关联。
- 配对样本间免疫浸润差异(肿瘤减非肿瘤)比非肿瘤或肿瘤组织中的表达更具预后价值。
- 肿瘤样本中观察到的B细胞受体(BCR)/T细胞受体(TCR)克隆型多于癌旁非肿瘤样本,且BCR克隆性增加。
- 在腺癌样本中,较高的组织学模式复杂度与肿瘤邻近区域较高的免疫浸润和低TCR克隆性相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: In recent years, the proportion of patients with NSCLC diagnosed at an early stage has increased continuously. METHODS: In this study, we analyzed samples and data collected from 119 samples from 67 early stage patients with NSCLC, including 52 pairs of tumor and adjacent non-neoplastic samples, and performed RNA-sequencing analysis with high sequencing depth. RESULTS: We found that immune-related genes were highly enriched among the differentially expressed genes and observed significantly higher inferred immune infiltration levels in adjacent non-neoplastic samples than in tumor samples. In survival analysis, the infiltration of certain immune cell types in tumor, but not adjacent non-neoplastic, samples were associated with overall patient survival, and excitingly, the differential infiltration between paired samples (tumor minus non-neoplastic) was more prognostic than expression in either non-neoplastic or tumor tissues. We also performed B cell receptor (BCR) and T cell receptor (TCR) repertoire analysis and observed more BCR/TCR clonotypes and increased BCR clonality in tumor than in non-neoplastic samples. Finally, we carefully quantified the fraction of the five histologic subtypes in our adenocarcinoma samples and found that higher histologic pattern complexity was associated with higher immune infiltration and low TCR clonality in the tumor-proximal regions. CONCLUSIONS: Our results indicated significantly differential immune characteristics between tumor and adjacent non-neoplastic samples and suggested that the two regions provided complementary prognostic values in early-stage NSCLCs.
引用
- Cheng C, Nguyen TT, Tang M, et al. Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer. J Thorac Oncol. 2023. PMID: 37146750. doi:10.1016/j.jtho.2023.04.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。